Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Tamai
Noriyuki
N
Department of Orthopaedics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. tamai@ort.med.osaka-u.ac.jp
Hashii
Yoshiko
Y
Osuga
Keigo
K
Chihara
Tsuyoshi
T
Morii
Eiichi
E
Aozasa
Katsuyuki
K
Yoshikawa
Hideki
H
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D057645:Deltoid Muscle / Q000473:pathology / Q000648:ultrastructure; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000648:ultrastructure; D006390:Hemangioendothelioma / Q000175:diagnosis / Q000188:drug therapy / Q000648:ultrastructure; D018324:Hemangioma, Capillary; D006392:Hemangioma, Cavernous / Q000175:diagnosis / Q000188:drug therapy / Q000648:ultrastructure; D006801:Humans; D007223:Infant; D059885:Kasabach-Merritt Syndrome; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000188:drug therapy / Q000648:ultrastructure; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000648:ultrastructure; D013921:Thrombocytopenia / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D019043:Vascular Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000648:ultrastructure
D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone